Long Term Investments - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Long-Term Investments Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Long-Term Investments
ÂŁ1.2B
CAGR 3-Years
-29%
CAGR 5-Years
-7%
CAGR 10-Years
-3%
A
AstraZeneca PLC
NASDAQ:AZN
Long-Term Investments
$1.9B
CAGR 3-Years
19%
CAGR 5-Years
5%
CAGR 10-Years
18%
Indivior PLC
LSE:INDV
Long-Term Investments
$26m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Long-Term Investments
$63m
CAGR 3-Years
21%
CAGR 5-Years
16%
CAGR 10-Years
1%
Allergy Therapeutics PLC
LSE:AGY
Long-Term Investments
ÂŁ5.3m
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
5%
Dechra Pharmaceuticals PLC
LSE:DPH
Long-Term Investments
ÂŁ14.9m
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is GlaxoSmithKline PLC's Long-Term Investments?
Long-Term Investments
1.2B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Long-Term Investments amounts to 1.2B GBP.

What is GlaxoSmithKline PLC's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
-3%

Over the last year, the Long-Term Investments growth was -15%. The average annual Long-Term Investments growth rates for GlaxoSmithKline PLC have been -29% over the past three years , -7% over the past five years , and -3% over the past ten years .

Back to Top